CLDX
Celldex TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
CLDX vs peer average
47/100
CLDX vs. peer average (C vs. C)
Grade spread
A 1 · B 4 · C 3 · D 2 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ANIP is the first available peer comparator.
ANI Pharmaceuticals is a loose comp given its more commercial profile, but the contrast highlights that CLDX still trades mainly on binary development milestones rather than operating leverage.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
CLDX
Celldex Therapeutics
ANIP
ANI
Grade
C
B
Momentum
45
45
Value
41
67
Sentiment
67
70
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Mixed
Constructive
Grade position vs ANIP
CLDX / ANIP
Grade Position
In line
CLDX vs. peer average (C vs. C)
47/100
Momentum
45
CLDXValue
41
ANIPSentiment
67
ANIPRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs CLDX
ANIP is the first peer returned for this comparison set.